11/06/2025

Search Posts FDA approval

Celltrion Secures Interchangeability Approval for Humira Biosimilar in the U.S.

Celltrion Secures Interchangeability Approval for Humira Biosimilar in the U.S.

April 14, 2025

Research Unveils Innovative Drug Delivery System for Rare Eye Cancer

Research Unveils Innovative Drug Delivery System for Rare Eye Cancer

April 11, 2025

Celltrion Aims for $3.46 Billion in Sales This Year Powered by Biosimilars

Celltrion Aims for $3.46 Billion in Sales This Year Powered by Biosimilars

March 18, 2025

Celltrion Unveils New Treatment for Autoimmune Disorders in the US

Celltrion Unveils New Treatment for Autoimmune Disorders in the US

March 13, 2025

Celltrion Secures USFDA Nod for Allergic Asthma Biosimilar

Celltrion Secures USFDA Nod for Allergic Asthma Biosimilar

March 10, 2025

Celltrion's Biosimilars for Bone Disorders Gain US Approval

Celltrion's Biosimilars for Bone Disorders Gain US Approval

March 4, 2025

FDA Greenlights New Painkillers to Combat Opioid Addiction Risks

FDA Greenlights New Painkillers to Combat Opioid Addiction Risks

February 1, 2025

Celltrion Secures FDA Approval for New Autoimmune Disease Biosimilar

Celltrion Secures FDA Approval for New Autoimmune Disease Biosimilar

January 31, 2025

Eli Lilly's Zepbound Positioned to Lead the Global Obesity Sector: Report

Eli Lilly's Zepbound Positioned to Lead the Global Obesity Sector: Report

December 31, 2024

Four Oral GLP-1R Drugs Compete for Approval, Led by Novo Nordisk: Report

Four Oral GLP-1R Drugs Compete for Approval, Led by Novo Nordisk: Report

December 2, 2024